Advertisement
Organisation › Details
Columbus Venture Partners S.G.E.I.C., S.A.
Columbus Venture Partners is a Spanish independent venture capital that brings a unique approach for investing in outstanding early-stage and high growth opportunities in the life science industry of Spain. Columbus has $275M under management through three funds. Our team includes solid and internationally experienced investment professionals with a deep scientific, medical and business development background combined with a proven experience in building and investing in companies to accelerate their commercialization. The combination of industry possibilities and investment experience will provide Limited Partner investors in the Fund a level of professionality and deep expertise that is essential for success in this field. *
Start | 2017-01-01 established | |
Group | Columbus Venture Partners (Group) | |
Industry | venture capital | |
Industry 2 | LIFE SCIENCES | |
Person | Tormo, Damià (Columbus Venture Partners 201906) | |
Person 2 | García, Javier (Columbus Venture Partners 202107 General Partner + Founder) | |
Region | Madrid | |
Country | Spain (España) | |
Street | 58 C/ José Abascal 7D | |
City | 28003 Madrid | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | EUR | |
Annual sales | 275,000,000 (assets, managed (2021) 2021-07-07) | |
* Document for »About Section«: Nerre Therapeutics Ltd.. (7/7/21). "Press Release: Nerre Therapeutics Raises £20 Million in a Series B2 Financing Round". Stevenage. | ||
Record changed: 2022-06-02 |
Advertisement
More documents for Columbus Venture Partners (Group)
- [1] Minoryx Therapeutics S.L.. (5/31/22). "Press Release: Minoryx Raises €51 Million to Support Marketing Authorization Application and Launch Preparations for X-linked Adrenoleukodystrophy (X-ALD) therapy". Mataró, Barcelona....
- [2] Integra Thepeutics S.L.. (3/29/22). "Press Release: Integra Therapeutics Closes a New Investment of €1.5 Million with the Addition of Columbus Venture Partners to Seed Round". Barcelona....
- [3] Nerre Therapeutics Ltd.. (7/7/21). "Press Release: Nerre Therapeutics Raises £20 Million in a Series B2 Financing Round". Stevenage....
- [4] Artax Biopharma, Inc.. (6/4/20). "Press Release: Artax Biopharma Announces Series B Financing Extension to Advance First-in-Class Autoimmune Disease Therapy". Cambridge, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top